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Early diagnosis is a tenet in oncology and should enable early treatment with the expectation of improved outcome. Extent
and determinants of patient delay of diagnosis in breast cancer patients and its impact on stage of disease were examined in a
population based study among female breast cancer patients in Germany. Two hundred and eighty-seven women, aged 18 to
80 years with newly diagnosed invasive symptomatic breast cancer, were interviewed with respect to the diagnostic process.
Patient delay was deﬁned as time from onset of ﬁrst symptoms to ﬁrst consultation of a doctor. Median patient delay was 16
days among symptomatic patients. Eighteen per cent of all breast cancer patients waited longer than 3 months before
consulting a physician. Long patient delay was associated with old age, history of a benign mastopathy, obesity, and indices of
health behaviour such as not knowing a gynaecologist for out-patient care and non-participation in general health screening
examinations. A strong association between patient delay and stage at diagnosis was observed for poorly differentiated
tumours. These results suggest that at risk groups for delaying consultation can be identiﬁed and that a substantial proportion
of late stage diagnoses of poorly differentiated breast cancer cases could be avoided if all patients with breast cancer
symptoms would present to a doctor within 1 month.
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Early diagnosis is a tenet in oncology and should enable early treat-
ment with the expectation of improved outcome. Screening
programmes have been introduced for common cancer types such
as breast or colorectal cancer in many countries. However, most
cancer cases are detected after the onset of symptoms. Any addi-
tional delay in diagnosis and treatment is likely to worsen
prognosis of cancer patients.
In general, delay in diagnosis and treatment of cancer is divided
into patient and provider delay (Facione, 1993). Patient delay is
deﬁned as the period from ﬁrst onset of symptoms to ﬁrst medical
consultation. Provider delay covers the period from ﬁrst consulta-
tion to deﬁnite diagnosis and treatment.
There is quite substantial evidence that among breast cancer
cases patient delay of more than 3 months is associated with lower
survival whereas no such association has been found for provider
delay (Afzelius et al, 1994; Coates, 1999; Richards et al, 1999; Sains-
bury et al, 1999).
Pertinent studies suggest an association between patient delay
and various socio-economic factors, such as old age and ethnicity.
A recent review (Ramirez et al, 1999) indicated that most studies
done so far were deemed to be of poor quality and that the
strength of the current evidence is inadequate to develop speciﬁc
strategies to shorten patient delay. One major limitation of many
pertinent studies, both population and hospital based, is that they
rely on secondary data, such as hospital records, which are often
obtained in non-standardised manner and usually include only a
limited range of potential covariates. In addition, the underlying
causes why patients are delaying seeking care have rarely been
examined.
We tried to address some of the aforementioned shortcomings
by collecting extensive information about the preclinical period
directly from the patients in a population based setting. The objec-
tives of this study were to assess extent, nature and length of
duration of symptoms in breast cancer patients, to identify poten-
tial predictors of long delay and to examine the association
between patient delay and stage at diagnosis.
MATERIALS AND METHODS
Study design and study population
A population-based, statewide study on diagnostic delay and late
stage diagnosis was conducted among patients with various forms
of cancer in Saarland, a state with about 1 million inhabitants in
Western Germany (Verlauf der diagnostischen Abkla ¨rung, VERDI).
Details of the study have been reported elsewhere (Arndt et al,
2001). For the purpose of this study, all women aged 18 to 80 years
who were residents of the state of Saarland with primary, sympto-
matic and invasive breast cancer of any histological type, diagnosed
between 1 October, 1996 and 28 February, 1998, were eligible.
Patients with recurrent disease at the time of the interview, who
died before the interview, who were not fully informed about their
breast cancer diagnosis, or with no or only little German language
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oncologists and radio-therapists from all hospitals in Saarland
and all adjacent counties identiﬁed potential study participants.
After written informed consent, 458 breast cancer patients were
reported to the study centre representing about 57% of all new
incident cases aged 18 to 80 years during the recruitment period
according to projections by the Saarland Cancer Registry. Asymp-
tomatic women whose tumours were detected by screening (n=67)
or incidentally during the diagnostic work-up of a different disease
(n=26) and also symptomatic patients who did not meet all of the
above mentioned inclusion criteria (n=64) were excluded for this
analysis. Overall, 287 out of 301 eligible women reported to the
study centre with symptomatic breast cancer could be recruited
(response rate=95.3%). The study participants did not substantially
differ from the source population in terms of basic sociodemo-
graphic characteristics with the exception of a slightly higher
proportion of younger patients.
Data collection
Structured face-to-face interviews were administered either during
the ﬁrst hospitalisation due to breast cancer (63%) or, in case
the patient already had been discharged, in respondents’ homes
(37%). Fifty per cent of all interviews took place within 3 weeks
after diagnosis and 90% within 8 weeks after diagnosis. The inter-
views were conducted by trained physicians and required 45 to
90 min to complete. The interviews contained detailed questions
concerning disease history from ﬁrst complaint to deﬁnite diagno-
sis, general health status, health practices, availability of health
services, social network and socio-economic factors. Nature of ﬁrst
symptoms was categorised into lump, breast symptoms other than
lump and symptoms not related to the breast. In addition, histo-
pathological data and results from clinical examinations were
abstracted from the hospital records of each study participant.
Information regarding tumour stage relied on histopathological
(T, N) and clinical data (M). Staging was carried out within 1
month after the ﬁrst consultation of a physician in over 75% of
all patients.
Measure of patient delay
Patient delay was deﬁned as the duration of symptoms in days
before the ﬁrst medical consultation. In order to minimise recall
bias, the study participants were asked to remember the onset of
symptoms and the day of ﬁrst consultation with the help of a
calendar rather than reporting the corresponding time lag. As in
most other pertinent studies, patient delay was then categorised
into periods of less than 1 month, 1 to 3 months and more than
3 months.
Statistical methods
To test the association between socio-economic, health behaviour,
as well as health related factors and patient delay, age adjusted w
2-
tests using Cochran–Mantel–Haenszel–Statistics were employed.
Socio-economic factors included nationality (German, other), place
of residence (510000, 10000 to 5100000, 5100000 inhabi-
tants), living arrangements (living alone, with spouse only, with
spouse and others, with others – not spouse), education (510
years, 510 years), current employment status (housewife/retired,
employed, unemployed), most recent occupation (white collar,
blue collar, never worked), and health insurance (non private,
private). Indicators of health behaviour included frequency of
breast self examination (51/month, 51/month), history of profes-
sional breast cancer screening (ever/never during past 5 years) and
general health check-up examinations (ever/never during past 5
years). Patients were also asked whether they had a gynaecologist
for out-patient care prior to the onset of the current disease. A
proxy measure of interest in health issues was deﬁned as the
number of sources through which the patient informed herself
about health issues before the current disease became apparent.
The lowest tertile was considered to represent low interest in health
issues. Further covariates describing health characteristics or family
history included body mass index (BMI), comorbidity (deﬁned as
being treated for cardiovascular disease, diabetes mellitus, asthma,
chronic obstructive pulmonary disease, other cancers, or arthritis
during the past year), history of benign mastopathy, use of
hormones (contraceptives or hormone replacement therapy)
during the year before diagnosis and history of breast cancer
among a ﬁrst degree relative.
To identify the most inﬂuential and independent determinants
of patient delay (43 months vs 1 to 3 months vs 51 month), a
proportional odds regression with stepwise variable selection was
performed. The signiﬁcance levels for entering into and staying
in the model were both set to 0.15. After checking the proportional
odds assumption, we ran additional logistic models with intermedi-
ate (1 to 3 months) and long (43 months) patient delay as two
distinct binary outcomes. In both models, women with short delay
(51 month) represented the reference group.
Finally, we described the association between patient delay and
tumour stage stratiﬁed by tumour grade. Stage of disease was cate-
gorised as ‘localised’, ‘regional’ or ‘distant’ according to TNM
staging scheme (Esteban et al, 1995). ‘Localised’ disease included
all cases with T1 to T3 and N0/M0, ‘regional’ included all N1 to
N3/M0 or T4/N0/M0 and ‘distant’ comprised all cases with M1.
For the present study the relatively small number of ‘distant’
disease (n=10) was combined with ‘regional’ (n=138) to represent
late stage disease in contrast to early (localised) disease.
RESULTS
Study population
The characteristics of the study population (n=287) are shown in
Table 1. The mean age of all women was 57.3 years. A small minority
was non-German and less than a quarter had 10 or more years of
education. Tumour spread at time of diagnosis was conﬁned to the
breast in 48.4% of all women, whereas 51.6% of all patients already
showed evidence of more advanced disease. Symptoms of the breast
were the trigger to consult a physician in over 96% of all women. A
lump in the breast was the ﬁrst symptom in 2 out of 3 women
(66.9%). Other symptoms of the breast such as an inverted nipple,
skin oedema, peau d’orange, discharge or bleeding were reported less
frequently (29.6%). The majority of all women consulted a doctor
within the ﬁrst month. The median patient delay was 16 days but 1
out of 6 women (17.4%) waited more than 3 months before seeking
professional health care.
Reasons for delaying seeking care
Considering symptoms as harmless was the most important reason
for more than half of the patients (55.3%) to delay seeking doctors’
advice for more than 1 month (Table 2). This ﬁnding did not
substantially vary when patients’ answers were stratiﬁed by dura-
tion of symptom, age or type of ﬁrst symptom. Time constraints
(14.6%) and considering symptoms as temporary (13.6%) were
the second and third most common reasons for patient delay.
Older women tended to consider their symptoms as temporary
more often than middle aged or younger women (20.5% vs
11.6% vs 4.8%). Although the data rely on small numbers, this
trend was statistically signiﬁcant (Ptrend=0.02).
Determinants of long patient delay
Bivariate analysis indicated a strong association between age and
patient delay (Table 3). In general, older women waited longer
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cian (P=0.01). For example, a patient delay of more than 3 months
was over three times more often reported by women over 65 years
of age (24.7%) than among women under 50 years of age (7.1%).
Because of the important role of age, adjustment for age was
applied in all further analyses regarding determinants of patient
delay. None of the other socio-economic factors was signiﬁcantly
associated with patient delay.
Among variables describing health characteristics, obesity
showed the strongest association with patient delay (Table 4).
The proportion of women waiting over 3 months was 25.7%
among women with BMI 430 kg m
72 compared to 15.0% for
women with BMI in the range 25 to 30 kg m
72 and 13.5% for
women with BMI 525 kg m
72 (P=0.02). After controlling for
age this difference was still visible but was no longer statistically
signiﬁcant (P=0.09).
Women who already had a gynaecologist for out-patient care
prior to the onset of symptoms or women who attended a general
health check-up during the last 5 years also sought professional
medical advice earlier than women who did not (P50.05 in crude
and age standardised analyses). Patient delay tended to be slightly
less common among women who reported at least monthly breast
self examination or women who underwent professional breast
cancer screening during the past 5 years but the differences were
small and not statistically signiﬁcant. There were also minor,
non-signiﬁcant differences in patient delay according to tumour
characteristics such as tumour differentiation (P=0.07) and nature
of ﬁrst symptoms (P=0.24). If anything, patients with more aggres-
sive tumours (GIII/GIV) tended to present faster to a doctor than
women with better differentiated tumours (GI/GII), and patient
delay was somewhat shorter among women who noticed a lump
as ﬁrst symptom compared to other women.
Multivariate analysis Results of the multivariate analysis are
shown in Table 5. Older age, higher body mass index, a history
of benign mastopathy, not knowing a gynaecologist for out-patient
care, and not having a general health check-up during the past 5
years prior to the onset of breast cancer symptoms were identiﬁed
as the most predictive and independent variables in a proportional
odds model comparing patient delay 43 months vs 1 to 3 months
vs 51 month. Examining the proportional odds-assumption
revealed heterogeneity in the strength of the association between
length of delay and some of the predictors (in particular ‘body
mass index’ and ‘not knowing an out-patient gynaecologist’).
We therefore evaluated the association between all ﬁve variables
and intermediate (1 to 3 months) and long (43 months) patient
delay in two separate logistic models. Short patient delay (51
month) represented the reference group in both models. All of
the above identiﬁed predictors were statistically signiﬁcant determi-
nants in the model comparing patient delay 43 months vs 51
month, whereas the observed associations between most of these
variables and intermediate patient delay (1 to 3 months) were
generally weaker when conﬁning the analysis to patient delay of
less than 3 months. To rule out possible residual confounding by
age, we performed additional analyses with a linear and a quadratic
age term that revealed virtually unchanged effect estimates (data
not shown).
Association between patient delay and tumour stage
Late stage breast cancer was found in 51.6% of all patients (Table
6) and it tended to be more frequent among women with patient
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n %
Total 287 100.0
Socio-economic characteristics
Age (years)
550 85 29.6
50–65 121 42.2
465 81 28.2
mean, standard deviation 57.3 12.3
Nationality
German 278 96.9
Other 9 3.1
Education
510 years 215 75.2
10 years and more 71 24.8
Tumour characteristics
Stage
Localised 139 48.4
Regional 138 48.1
Distant 10 3.5
Grading
GI/II 152 53.3
GIII/IV 133 46.7
Symptoms
Lump 192 66.9
Breast other than lump 85 29.6
Other (arm, axilla, distant) 10 3.5
Patient delay
51 month 183 64.1
1–3 months 53 18.5
43 months 50 17.4
median, interquartile range (days) 16 4–59
Table 2 Reported main reason for patient delay 41 month according to length of delay, age and ﬁrst symptom
Patient delay Age Symptom
1–3
months 4 43m 3 months onths 5 550 years
50–65
years 4 465 y 65 years ears Lump Other Total
n Col % n Col % n Col % n Col % n Col % n Col % n Col % n Col %
Considered symptoms as:
Harmless 28 52.8 29 58.0 12 57.1 25 58.1 20 51.3 33 52.4 24 60.0 57 55.3
Temporary 7 13.2 7 14.0 1 4.8 5 11.6 8 20.5 8 12.7 6 15.0 14 13.6
Time constraints 7 13.2 8 16.0 4 19.1 5 11.6 6 15.4 9 14.3 6 15.0 15 14.6
Fear of diagnostics, surgery 5 9.4 4 8.0 2 9.5 4 9.3 3 7.7 7 11.1 2 5.0 9 8.7
Had to wait for an appointment 4 7.6 0 0.0 1 4.8 2 4.7 1 2.6 3 4.8 1 2.5 4 3.9
Other, not stated 2 3.8 2 4.0 1 4.8 2 4.7 1 2.6 3 4.8 1 2.5 4 3.9
Total 53 100 50 100 21 100 43 100 39 100 63 100 40 100 103 100
Percentages within each column.
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doctor within 1 month after onset of symptoms (48.9%;
Ptrend=0.22). There was a remarkable difference in the association
between patient delay and stage at diagnosis of breast cancer when
stratiﬁed by tumour differentiation, however. Among well differen-
tiated tumours (GI/GII), the proportion of late stage breast cancer
did not change with increasing patient delay (Ptrend=0.83), whereas
a monotonic trend between length of patient delay and late stage
diagnosis was observed among women with poorly differentiated
breast tumours (Ptrend=0.03).
Given a mean proportion of 48.9% of late stage diagnosis among
women with short delay (51 month), 140 (=287648.9%) late stage
breast cancer cases would have been expected in our study sample if
all women had attended a doctor within 1 month after onset of symp-
toms. Given that 148 women in our sample presented with late stage
disease, we estimate that late stage diagnosis might perhaps have been
prevented in 8 out of 58 (13.8%) women with patient delay 51
month. As noted above, our data indicate that the association
between patient delay and tumour stage seems to be restricted to
women with poorly differentiated breast cancer tumours. The corre-
sponding proportion of possibly preventable late stage diagnoses
amounts to 8 out of 28 (28.6%) cases among women with poorly
differentiated breast cancer tumours.
DISCUSSION
Breast cancer is not a medical emergency but the procrastination of
onset of diagnostic work-up and treatment is likely to result in
further advanced disease and its probable sequels like more invasive
surgery or higher cause speciﬁc mortality.
The median patient delay in our population based study was 16
days. This is in agreement with ﬁndings from pertinent studies
published during the last decade (Coates et al, 1992; Afzelius et
al, 1994; Burgess et al, 1998) and is further evidence of a favourable
trend towards shorter delay during the last two decades when
compared with earlier studies (Cameron and Hinton, 1968; Dennis
et al, 1975; Fisher et al, 1977; Elwood and Moorehead, 1980;
MacArthur and Smith, 1981; Dohrmann et al, 1982; Vernon et
al, 1985; Neale et al, 1986). This trend might be attributable to
an increasing health awareness among women due to extensive
information campaigns which address breast cancer warning signs
in many developed countries.
Despite these efforts, our study indicates that 1 out of 6
women (17.4%) aged 18 to 80 years with symptomatic breast
cancer is still waiting 3 months or more before ﬁrst consultation
of a doctor. Since older people seem to delay longer, the overall
proportion might even be higher if we had included patients aged
over 80 years. Downplaying the signiﬁcance of breast related
symptoms seems to represent a major cause for delay, whereas
fear and difﬁculties in scheduling an appointment appear to play
a minor role in this context. This ﬁnding is similar to an earlier
report by Coates et al (1992), where delay was substantially caused
by naive perception regarding the vital signiﬁcance of breast
cancer symptoms.
We observed that patients’ characteristics associated with delay
comprise older age, history of benign mastopathy, obesity, not
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Table 3 Patient delay in breast cancer patients by socio-economic factors
Median delay
Proportions of patients with
delay (row %) Pw
2
n (days) 5 51 month 1–3 months 4 43m 3 months onths Crude Age adjusted
Total 287 16 64.1 18.5 17.4
Age (years)
550 85 12 75.3 17.7 7.1
50–65 121 14 64.5 15.7 19.8 0.01
465 81 24 51.9 23.5 24.7
Nationality
German 278 16 64.0 18.0 18.0 0.25 0.30
Foreign 9 19 66.7 33.3 0.0
Size of town (number of citizens)
510 000 160 16 63.8 15.6 20.6
10 000–99 999 94 17.5 63.8 21.3 14.9 0.36 0.39
5100 000 33 14 66.7 24.2 9.1
Living arrangement
Single 73 21 56.2 23.3 20.6
With other than spouse 36 22.5 58.3 22.2 19.4 0.13 0.64
With spouse only 101 16 64.4 13.9 21.8
With spouse and others 76 12.5 73.7 18.4 7.9
Education
510 years 215 16 62.8 18.6 18.6 0.49 0.98
10 years and more 71 14 69.1 18.3 12.7
Current employment status
Housewife/retired 176 20 60.8 19.3 19.9
Employed 93 13 72.0 17.2 10.8 0.28 0.68
Unemployed 16 25.5 56.2 18.8 25.0
Last occupational class
White collar 158 15 63.9 21.5 14.6
Blue collar 53 16 67.9 13.2 18.9 0.41 0.46
Never worked 71 16 62.0 15.5 22.5
Health insurance
Non private 252 16 64.7 17.5 17.9 0.37 0.36
Private 34 13.5 61.8 26.5 11.8
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not knowing a gynaecologist for out-patient care.
Older women are more prone to procrastinate early detection
of breast cancer resulting in more advanced disease and fewer
asymptomatic cases (Holmes and Hearne, 1981; Goodwin et
al, 1986; Lickley, 1997). Similar ﬁndings have been reported
from various countries (Polednak, 1986; Yancik et al, 1989;
Coates et al, 1992; Afzelius et al, 1994; Fowble et al, 1994;
Ramirez et al, 1999). Several explanations why patient delay is
more often found among older women have been suggested.
Older women may attribute early breast cancer symptoms to
comorbid conditions or normal ageing (Facione, 1993). There
is some evidence for this explanation in our data, if we look
at the high proportion among older women who considered
their symptoms as temporary. However, elderly people may also
be unaware of the fact that they are at higher risk compared to
younger women. Fatalism, e.g. a sense that one has lived long
enough, might be another reason for the higher proportion of
patient delay among older breast cancer patients (Facione,
1993; Goodwin et al, 1986; Lierman, 1988).
We are not aware of any other study that has examined the history
of benign mastopathy as a determinant of patient delay. One reason
why those women procrastinate seeking professional care might be
their experience that former episodes of similar breast tissue altera-
tions have been considered as benign by their gynaecologists. Thus, it
might be worthwhile to encourage women with known benign breast
disease to present new breast symptoms quickly to a gynaecologist in
order not to delay diagnosis of breast cancer.
In Germany, women may directly consult gynaecologists for out-
patient care of gynaecological disorders. Only a small proportion of
women will consult a family doctor with disorders of the breast.
Thus, not knowing a gynaecologist for out-patient care is an
obvious barrier causing delay of diagnostics. Since regular clinical
breast examinations are recommended as a breast cancer screening
measure and covered by all health insurance plans in Germany,
every woman should know a gynaecologist for out-patient care.
Reasons why some women don’t have a gynaecologist deserve
further study.
Similarly, a general health check-up is offered to all members of
regular health insurance plans aged 36 years and older in Germany
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Table 4 Patient delay in breast cancer patients by health characteristics, health behaviour and tumour related factors
Median delay
Proportions of patients with
delay (row %) Pw
2
n (days) 5 51 month 1–3 months 4 43m 3 months onths Crude Age adjusted
Health characteristics, family history
Body mass index
525 kg m
72 126 13 73.0 13.5 13.5
25–30 kg m
72 80 18.5 57.5 27.5 15.0 0.02 0.09
530 kg m
72 70 21 57.1 17.4 25.7
Comorbidity
1
No 113 14 69.0 13.3 17.7 0.18 0.22
Yes 174 17.5 60.9 21.8 17.2
History of benign mastopathy
No 216 13.5 65.3 19.0 15.7 0.42 0.21
Yes 71 21 60.6 16.9 22.5
Family history of breast cancer
No 250 16.5 63.2 19.2 17.6 0.65 0.69
Yes 37 7 70.3 13.5 16.2
Health behaviour
Knowing a gynaecologist for out-patient care
Yes 202 13.5 67.8 19.8 12.4 0.002 0.03
No 84 22.5 55.9 14.3 29.8
Breast self-examination
Yes, at least monthly 146 143 66.4 19.2 14.4 0.33 0.31
No, rarely (51/month) 127 16 61.4 17.3 21.3
Breast cancer screening during past 5 years
Yes 205 14 67.3 18.1 14.6 0.09 0.55
No 81 23 55.6 19.7 24.7
General health check-up during past 5 years
Yes 163 13 69.9 15.3 14.7 0.04 0.02
No 121 21 55.4 23.1 21.5
Interest in health issues
2
Regular 197 16 66.0 17.2 16.8 0.61 0.58
Low 90 17.5 60.0 21.1 18.9
Tumour characteristics
Grading
GI/II 152 20 61.2 16.5 22.4 0.07 0.13
GIII/IV 133 14 67.7 20.3 12.0
First symptom
Lump 192 14 67.2 17.7 15.1 0.24 0.40
Other 95 20 57.9 20.0 22.1
1Deﬁned as being treated for cardiovascular disease, diabetes mellitus, asthma, chronic obstructive pulmonary disease, other cancers or arthritis
during past year.
2Deﬁned by the number of sources reported by the patient to inform herself about health issues before the current disease
became apparent. The lowest tertile (43 sources) was considered to represent low interest in health issues.
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tude towards screening programmes and is likely to be a good
marker for health behaviour and general health care utilisation.
Thus it is not surprising to observe that women who attend the
general health check-up screening examination are more likely to
present their breast symptoms in a timely manner to a physician
than those who do not attend these screening examinations.
In contrast to utilisation of the general health check-up, breast
cancer screening behaviour either measured as breast self examina-
tion or professional breast examination (including but not
restricted to mammography) was not associated with patient delay
once age was controlled for. Although women who undergo breast
cancer screening tend to be more health conscious, they might feel
less worried about some vague alterations of the breast if the last
mammography or clinical examination had been normal. Other
studies show no clear evidence of an association between lack of
breast self examination and patient delay (Huguley et al, 1988;
Coates et al, 1992; Burgess et al, 1998).
The detection of a breast tumour is known to be impeded
among obese women assuming that increased BMI is a proxy
measure for increased breast size. Although several studies reported
an association between increasing body mass index and advanced
stage (Ingram et al, 1989; Hunter et al, 1993; Reeves et al, 1996)
it is not clear why obese women seem to wait longer to present
their breast cancer symptoms to a doctor. The results from our
multivariable analyses indicate that the association between body
mass index and patient delay is not explained by differences in
health behaviour (as measured in our study), social class or educa-
tion. One explanation could be that they notice some symptoms
but that these symptoms might be less impressive and distinct in
women with large breasts.
Most adult onset tumours are slow growing and have been
present one to several years at time of diagnosis. It is estimated
that the average breast cancer has been growing for 7 years at time
of diagnosis (Eckhardt, 1990). Thus a few days or weeks delay is
unlikely to make any signiﬁcant difference in long term outcome.
However, within our study population, there was a tendency
towards more advanced stage among women with patient delay
longer than 1 month. The absence of a signiﬁcant association
between patient delay and stage or survival observed in some
studies may reﬂect variations in growth rate (Gardner, 1978) as
expressed by tumour differentiation. When we stratiﬁed by tumour
grade, this association between patient’s delay and stage was stron-
ger among poorly differentiated tumours which tend to grow
faster. Our data indicate that a substantial proportion of late stage
diagnoses of poorly differentiated breast cancer cases could be
avoided if all patients with breast cancer symptoms would present
to a doctor within 1 month. A similar ﬁnding was reported by
Facione (1993) and Feldman et al (1983), who also described a
stronger association between delay and survival among women
with more aggressive tumours.
A major strength of our study was the careful and detailed
collection of information on patient delay in personal interviews
conducted by trained personnel in addition to obtaining all perti-
nent information from medical records. In general, recall of delay
and symptoms is considered to be fairly high (Porta et al, 1996).
Collecting information regarding date of onset of symptoms and
date of ﬁrst consultation is probably more reliable than asking
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Table 5 Determinants of long patient delay in breast cancer patients
Proportional odds-regression
a Binary logistic regression I Binary logistic regression II
43 months vs 1–3 months vs
5 51 month (n=273)
1–3 months vs 5 51 month
(n=226)
4 43m 3 months onths vs vs 5 51 month
(n=223)
Crude OR Adjusted OR
b Crude OR Adjusted OR
b Crude OR Adjusted OR
b
Variable (95 CI) (95 CI) (95 CI) (95 CI) (95 CI) (95 CI)
Age
550 years 1.0 (referrent) 1.0 (referrent) 1.0 (referrent) 1.0 (referrent) 1.0 (referrent) 1.0 (referrent)
50–65 years 1.8 (1.0–3.4) 1.9 (1.0–3.6) 1.0 (0.5–2.2) 1.2 (0.5–2.7) 3.2 (1.3–8.5) 2.8 (1.0–7.8)
465 years 2.9 (1.5–5.6) 2.4 (1.1–5.1) 1.9 (0.9–4.2) 2.1 (0.8–5.4) 5.1 (1.9–13.7) 3.8 (1.2–11.6)
BMI
525 kg m
72 1.0 (referrent) 1.0 (referrent) 1.0 (referrent) 1.0 (referrent) 1.0 (referrent) 1.0 (referrent)
25–30 kg m
72 1.8 (1.0–3.2) 1.6 (0.9–3.0) 2.6 (1.3–5.4) 2.6 (1.2–5.8) 1.4 (0.6–3.2) 1.3 (0.5–3.2)
530 kg m
72 2.1 (1.2–3.9) 2.0 (1.0–3.9) 1.6 (0.7–3.7) 1.8 (0.8–4.6) 2.4 (1.1–5.2) 2.4 (1.0–5.7)
History of benign mastopathy 1.3 (0.8–2.2) 1.9 (1.0–3.4) 1.0 (0.5–2.0) 1.1 (0.5–2.4) 1.5 (0.8–3.1) 2.7 (1.2–6.2)
No out-patient gynaecologist 1.9 (1.2–3.2) 1.5 (0.8–2.7) 0.9 (0.4–1.8) 0.6 (0.3–1.5) 2.9 (1.5–5.6) 2.3 (1.1–4.8)
No general health check-up 1.8 (1.1–2.9) 2.2 (1.3–3.6) 1.9 (1.0–3.5) 2.2 (1.1–4.3) 1.8 (1.0–3.5) 2.4 (1.2–4.9)
during past 5 years
Abbreviations: OR=odds ratio, 95 CI=95% conﬁdence interval.
aStepwise model selection (Pentry, stay=0.15), proportional odds assumption rejected.
bAdjusted for all variables
presented in the table; estimates virtually unchanged in models with a linear and a quadratic age term (data not shown).
Table 6 Patient delay and risk of late stage breast cancer at time of surgery by tumour differentiation
Late stage diagnosis
a
All women (n=287) GI/II (n=152) GIII/IV (n=133)
Patient delay % OR (95 CI) % OR (95 CI) % OR (95 CI)
51 month 48.9 1.0 (referrent) 51.6 1.0 (referrent) 46.7 1.0 (referrent)
1–3 months 54.7 1.3 (0.7–2.3) 48.0 0.9 (0.4–2.1) 59.3 1.7 (0.7–4.0)
43 months 58.0 1.4 (0.8–2.7) 50.0 0.9 (0.4–2.1) 75.0 3.4 (1.0–11.4)
Ptrend 0.22 0.83 0.03
aLate stage diagnosis=lymph node involvement or distant spread of breast cancer at time of surgery. Abbreviations:
OR=odds ratio, 95 CI=95% conﬁdence interval.
Patient delay and breast cancer
V Arndt et al
1039
ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(7), 1034–1040patients directly about length of delay and also more accurate than
using data based on hospital records which are often obtained in a
non standardised manner. In general, hospital data also do not
provide information regarding causes of delay, and the duration
of symptoms obtained from hospital records is likely to comprise
both patient delay and provider delay until the date of hospitalisa-
tion.
A further advantage of our study is the assessment and analysis
of a wide range of individual factors that might inﬂuence patient’s
behaviour. To our knowledge, this work is unique in looking
simultaneously at socio-economic, health behaviour and other
related factors in a population based sample of breast cancer
patients.
CONCLUSIONS
These results suggest that at risk groups for delaying consultation
can be identiﬁed and that a substantial proportion of late stage
diagnoses of poorly differentiated breast cancer cases could be
avoided if all patients with breast cancer symptoms would present
to a doctor within 1 month.
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